BioAffinity Technologies Inc (NASDAQ:BIAF) currently has a daily average trading volume of 11.57M but it saw 4632181 shares traded in last market. With a market cap of 7.71M USD, the company’s current market price of $0.28 came falling about -3.12 while comparing to the previous closing price of $0.29. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.99 and as low as $0.16.
Over the week, BIAF’s stock price is moving 25.78% up while it is -44.51% when we observe its performance for the past one month. Year-to-date it is -68.90% down and over the past year, the stock is showing a downside performance of -87.48%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.12 while estimate for next year EPS is -0.45. In next quarter, company is expected to be making quarterly sales of $1.32M as analysts are expecting the sales for current fiscal year at $6.05M and seeing the company making $7.25M in sales next year. Moreover, analysts are in estimates of $1.21M for current-quarter revenue.
Currently, BioAffinity Technologies Inc’s total number of outstanding shares is 18.26M with 25.23% of that held by the insiders while 1.88% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -456.80% and return on equity (ROE) at -290.85%. Stock’s beta reads 2.70. Stock has a price to book (P/B) ratio of 3.59 while price to sale or P/S ratio amounts to 0.88. Its return on asset (ROA) is -143.25% on average.
